Astec Lifesciences Ltd
₹726.50
+5.15 (0.71%)
Fri, 23 Oct 2026, 02:08 pm
Process Industries
Chemicals: Agricultural
24.5KAstec Lifesciences Shareholding
| Shareholders | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 |
|---|---|---|---|---|---|
| Promoters | 71.96 | 71.97 | 71.97 | 72.42 | 70.87 |
| FII | 0.01 | 0.02 | 0.04 | 0.00 | 0.02 |
| DII | 3.33 | 3.34 | 3.17 | 4.01 | 4.26 |
| Public | 24.69 | 24.67 | 24.82 | 23.57 | 24.84 |
| Government | 0 | 0 | 0 | 0 | 0 |
Astec Lifesciences Ltd Shareholding Pattern
The Astec Lifesciences Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Astec Lifesciences Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Astec Lifesciences Ltd (NSE: ASTEC, BSE: 533138) operates in the Process industries sector and Chemicals: agricultural industry. Monitoring the Astec Lifesciences Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Astec Lifesciences Ltd Shareholding Pattern (Latest)
The latest Astec Lifesciences Ltd shareholding for Jun 2026 is:
- Promoters: 71.96%
- FII: 0.01%
- DII: 3.33%
- Public: 24.69%
- Government: 0%
A slight decline in promoter holding may indicate stake dilution or strategic selling.
Astec Lifesciences Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Astec Lifesciences Ltd.
- Jun 2026: 71.96%
- Mar 2026: 71.97%
- Dec 2025: 71.97%
- Sept 2025: 72.42%
- Jun 2025: 70.87%
Promoter stake remains largely stable, showing consistent ownership structure.
Astec Lifesciences Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Astec Lifesciences Ltd.
- Jun 2026: 0.01%
- Mar 2026: 0.02%
- Dec 2025: 0.04%
- Sept 2025: 0.00%
- Jun 2025: 0.02%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Astec Lifesciences Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Jun 2026: 3.33%
- Mar 2026: 3.34%
- Dec 2025: 3.17%
- Sept 2025: 4.01%
- Jun 2025: 4.26%
DII holdings remain stable, reflecting steady institutional participation.
Astec Lifesciences Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Jun 2026: 24.69%
- Mar 2026: 24.67%
- Dec 2025: 24.82%
- Sept 2025: 23.57%
- Jun 2025: 24.84%
Public participation in Astec Lifesciences Ltd has increased, indicating rising retail investor interest.
Astec Lifesciences Ltd Government Holding
Government holding in Astec Lifesciences Ltd currently stands at 0%.
Astec Lifesciences Ltd operates without significant government ownership.
Astec Lifesciences Ltd Shareholding Analysis Summary
The Astec Lifesciences Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Astec Lifesciences Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.
Regular monitoring of the Astec Lifesciences Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
